Telix Pharmaceuticals Limited
ASX: TLX
Telix Pharmaceuticals Limited is a biopharmaceutical company that focuses on oncology and develops and commercializes targeted radiopharmaceutical therapies. The company’s activities range from commercial sales, including Illuccix following regulatory approvals, to late-stage product development. The company is focused on prostate, kidney, and brai
🔒
Subscribers only
Sign in with your subscriber account or subscribe to access this research report.
Required subscription
Healthcare Pulse Report
A$1200.00
Already a subscriber?
Sign in to read this report.
Required subscription
Healthcare Pulse Report
Stay informed on Australia's healthcare sector with expert research covering healthcare, biotechnology, medical technology, and life sciences companies listed on the ASX.
- ✓ ASX Healthcare & Biotech Research
- ✓ Delivered Fortnightly every 2nd & 4th Tuesday
- ✓ Industry Trends & Risk Analysis
- ✓ Full Historical Report Access
A$1200.00/ 12 months
Risk:High
Subscribe Now →